High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引:0
作者
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5372
引用
收藏
页码:374B / 375B
页数:2
相关论文
共 50 条
[21]   Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma [J].
Gerrie, Alina S. ;
Power, Maryse M. ;
Savage, Kerry J. ;
Shepherd, John D. ;
Connors, Joseph M. .
BLOOD, 2011, 118 (21) :884-885
[22]   Autologous stem cell transplantation (ASCT) in non Hodgkin's lymphoma (NHL). A single center experience. [J].
Narni, F ;
Donelli, A ;
Sabbatini, R ;
Longo, G ;
Marasca, R ;
Savarino, M ;
Silingardi, V ;
Torelli, G .
BONE MARROW TRANSPLANTATION, 1999, 23 :S161-S161
[23]   Yttrium 90 Plus High Dose BEAM Conditioning with Autologous Stem Cell Transplantation (ASCT); Effects of Prior Rituximab and Outcome of Poor Risk Non Hodgkin Lymphoma (NHL) [J].
Krishnan, Amrita ;
Raubitschek, Andrew ;
Nademanee, Auayporn P. ;
Kogut, N. ;
Popplewell, Leslie ;
Tsai, Ni-Chun ;
Palmer, Joycelynne ;
Simpson, Jennifer ;
Federico, Laura ;
Yamauchi, Dave ;
Forman, Stephen J. .
BLOOD, 2009, 114 (22) :918-918
[24]   High-dose chemotherapy and peripheral hematopoietic stem cell transplantation in relapsed/refractory Hodgkin's lymphoma [J].
Kelta, Mouhammed ;
Zekri, Jamal ;
Abdelghany, Ehab ;
Rehman, Jalil Ur ;
Khan, Zahid Amin ;
Al-Saadil, Rawan ;
Dadai, Reyad .
TUMORI JOURNAL, 2018, 104 (06) :471-475
[25]   Safety of Zevalin® plus high dose chemotherapy and autologous stem cell transplantation (ASCT) in patients with relapsed or refractory NHL [J].
Madar, Olivier ;
Salmon, Maxime ;
Mounier, Nicolas ;
Madelaine-Chambrin, Isabelle ;
Faure, Pierre .
PHARMACY WORLD & SCIENCE, 2007, 29 (05) :505-506
[26]   High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis [J].
Gopal, AK ;
Gooley, TA ;
Maloney, DG ;
Petersdorf, SH ;
Eary, JF ;
Rajendran, JG ;
Bush, SA ;
Durack, LD ;
Golden, J ;
Martin, PJ ;
Matthews, DC ;
Appelbaum, FR ;
Bernstein, ID ;
Press, OW .
BLOOD, 2003, 102 (07) :2351-2357
[27]   High dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma. [J].
Holland, D. W. ;
Engelhardt, B. G. ;
Goodman, S. A. ;
Greer, J. P. ;
Morgan, D. S. ;
Schuening, F. G. ;
Wolff, S. ;
Bitting, R. ;
Sulur, P. ;
Stein, R. S. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :434S-434S
[28]   High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma [J].
Akhtar, S. ;
El Weshi, A. ;
Rahal, M. ;
Abdelsalam, M. ;
Al Husseini, H. ;
Maghfoor, I. .
BONE MARROW TRANSPLANTATION, 2010, 45 (03) :476-482
[29]   High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma [J].
S Akhtar ;
A El Weshi ;
M Rahal ;
M Abdelsalam ;
H Al Husseini ;
I Maghfoor .
Bone Marrow Transplantation, 2010, 45 :476-482
[30]   Second cancers after autologous hematopoietic stem cell transplantation (ASCT) for relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) [J].
Seshadri, Tara ;
Pintilie, Melania ;
Tsang, Richard ;
Kuruvilla, John ;
Zadeh, Sahar ;
Keating, Armand ;
Crump, Michael .
BLOOD, 2007, 110 (11) :499A-499A